PDT

UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting

Retrieved on: 
Thursday, April 25, 2024
Patient, Date, Research, PDT, Unity Biotechnology, Biotechnology, Therapy, DME, Ageing, Annual general meeting, UBX, ARVO, SAN, Pharmaceutical industry

SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that the Company will present two poster presentations at the Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting being held on May 5-9, 2024 in Seattle, Washington.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that the Company will present two poster presentations at the Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting being held on May 5-9, 2024 in Seattle, Washington.
  • Title: Effect of Patient Baseline Characteristics on Response to UBX1325, a Novel Senolytic Candidate For Patients With DME: BEHOLD Phase 2 Study 48 weeks follow-up
    Date & Time: Monday, May 6, 2024 at 8:30 – 10:15 a.m. PDT
    Date & Time: Wednesday, May 8, 2024 at 2:15 – 4:00 p.m. PDT

Doheny Eye Institute Announces Upcoming Presentations at ARVO 2024 Annual Meeting

Retrieved on: 
Wednesday, April 24, 2024
Grand Hyatt Seattle, Srinivas, Research, Diabetic retinopathy, PDT, MD, Doctor of Philosophy, Artificial intelligence, Booth, Neuro-ophthalmology, Eye, Breakfast, RSVP, Seattle Convention Center, Annual general meeting, Doheny Eye Institute, Pine Street, Imaging, ARVO, Knowledge

PASADENA, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Doheny Eye Institute , one of the nation’s leading vision research institutions, announced that more than 25 of its scientists and clinician-scientists will present their latest research during the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, the premiere gathering for eye and vision scientists from across the globe.

Key Points: 
  • PASADENA, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Doheny Eye Institute , one of the nation’s leading vision research institutions, announced that more than 25 of its scientists and clinician-scientists will present their latest research during the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, the premiere gathering for eye and vision scientists from across the globe.
  • Doheny Eye Institute and UCLA Stein Eye Institute will also be exhibiting together onsite at Booth #4515.
  • “Doheny Eye Institute is eager to share our latest findings and exchange insights with other leaders in vision research during the ARVO Annual Meeting,” said Deborah A. Ferrington, PhD, Chief Scientific Officer at Doheny Eye Institute.
  • At the conclusion of ARVO 2024, SriniVas R. Sadda, MD, the Director of Artificial Intelligence & Imaging Research at Doheny, will officially step into his role as President of ARVO.

Intuitive Announces First Quarter Earnings

Retrieved on: 
Thursday, April 18, 2024
FDA, Investment, Hysterectomy, Nasdaq, Inc., Certification, National Medical Products Administration, Intuition, PDT, SP, Da Vinci, Public expenditure, Patient, COVID-19, Diagnosis, Intuitive Surgical, GAAP, Growth, CE

First quarter 2024 revenue of $1.89 billion increased 11% compared with $1.70 billion in the first quarter of 2023.

Key Points: 
  • First quarter 2024 revenue of $1.89 billion increased 11% compared with $1.70 billion in the first quarter of 2023.
  • First quarter 2024 GAAP net income attributable to Intuitive was $545 million, or $1.51 per diluted share, compared with $355 million, or $1.00 per diluted share, in the first quarter of 2023.
  • First quarter 2024 non-GAAP* net income attributable to Intuitive was $541 million, or $1.50 per diluted share, compared with $437 million, or $1.23 per diluted share, in the first quarter of 2023.
  • First quarter 2024 GAAP income from operations increased to $469 million, compared with $388 million in the first quarter of 2023.

LogicMark, Inc. Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Thursday, April 18, 2024
Amazon (company), Aster, CFO, EDT, Internet of things, Safety, PDT, Software, E-commerce, Wi-Fi, Exercise, PERS, LGMK, Caregiver, Apple, Quality of life, Video game

Moreover, we achieved a 66% gross margin in the fourth quarter, an improvement of 450 bps from last year's fourth quarter.

Key Points: 
  • Moreover, we achieved a 66% gross margin in the fourth quarter, an improvement of 450 bps from last year's fourth quarter.
  • Revenue in the fourth quarter of 2023 was $2.4 million, a 13% increase from $2.1 million in the same period last year.
  • Gross profit in the fourth quarter of 2023 was $1.6 million, up 21% from $1.3 million in the same period last year.
  • Gross margin improved to 66.0% in the fourth quarter of 2023, a 450 bp increase from the same period last year.

Employers Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call

Retrieved on: 
Wednesday, April 17, 2024
EDT, Insurance, PIN, PDT, Webcast, EIG, Employment

The Company will then review these financial results via a conference call and webcast on Friday, April 26, 2024, at 11:00 a.m. EDT / 8:00 a.m. PDT.

Key Points: 
  • The Company will then review these financial results via a conference call and webcast on Friday, April 26, 2024, at 11:00 a.m. EDT / 8:00 a.m. PDT.
  • To participate in the live conference call, you must first register here .
  • The Company operates throughout the United States, with the exception of four states that are served exclusively by their state funds.
  • Insurance is offered through Employers Insurance Company of Nevada, Employers Compensation Insurance Company, Employers Preferred Insurance Company, Employers Assurance Company and Cerity Insurance Company, all rated A- (Excellent) by the A.M. Best Company.

Broad Arrow Announces Final Lineup for All-Porsche Auction in Partnership with Air|Water in Costa Mesa, California on April 27

Retrieved on: 
Wednesday, April 17, 2024
RUF, GT3, Porsche Carrera GT, Porsche Club of America, Spyder, PDT, Insurance, Partnership, IMSA, Digital, PCA, Index, Pleasure, Broad arrow, Pointe technique, Automotive industry

Air|Water will take place on Saturday, April 27thin Costa Mesa, California featuring both air-cooled and water-cooled Porsches of all eras.

Key Points: 
  • Air|Water will take place on Saturday, April 27thin Costa Mesa, California featuring both air-cooled and water-cooled Porsches of all eras.
  • The accompanying Broad Arrow auction consists of 57 outstanding Porsche motor cars and 41 lots of Porsche-themed memorabilia and will take place starting at 11:00 am PDT, all lots are now available for viewing at here .
  • This auction, in partnership with Air | Water and collaboration with PCA, reflects Hagerty and Broad Arrow’s continued commitment to the Porsche community to help Porsche enthusiasts to protect, buy/sell, and enjoy their Porsches.
  • More information about the Hagerty and Porsche Club of America partnership can be found here , and more information about PCA can be found here .

AMD to Report Fiscal First Quarter 2024 Financial Results

Retrieved on: 
Tuesday, April 16, 2024
AMD, PDT, EDT, Interest

SANTA CLARA, Calif., April 16, 2024 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) announced today that it will report fiscal first quarter 2024 financial results on Tuesday, Apr.

Key Points: 
  • SANTA CLARA, Calif., April 16, 2024 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) announced today that it will report fiscal first quarter 2024 financial results on Tuesday, Apr.
  • 30, 2024, after the close of market.
  • Management will conduct a conference call to discuss these results at 5:00 p.m. EDT / 2:00 p.m. PDT.
  • Interested parties are invited to listen to the webcast of the conference call via the AMD Investor Relations website ir.amd.com .

2024 DTA Summit Agenda is LIVE!!

Retrieved on: 
Tuesday, April 16, 2024
PFS, Single-frequency network, Policy, PDT, Digital, Medicare Sustainable Growth Rate, Therapy, CPT, Access, Medicare, H.R, Organization, DTA, Pharmaceutical industry

Arlington, VA, April 16, 2024 (GLOBE NEWSWIRE) -- Digital Therapeutics Alliance is excited to announce the launch of the highly anticipated agenda for the upcoming 2024 DTA Summit.

Key Points: 
  • Arlington, VA, April 16, 2024 (GLOBE NEWSWIRE) -- Digital Therapeutics Alliance is excited to announce the launch of the highly anticipated agenda for the upcoming 2024 DTA Summit.
  • The DTA Summit aims to bring together industry leaders, visionaries, and practitioners to explore the latest advancements and strategies shaping the future of digital transformation.
  • As organizations worldwide navigate unprecedented challenges and opportunities in the digital health landscape, the DTA Summit serves as a crucial platform for knowledge exchange, collaboration, and inspiration.
  • New in 2024, the DTA Summit will host a live Start-Up Pitch Competition.

Incyte to Present at Upcoming Investor Conference

Retrieved on: 
Thursday, May 2, 2024
Biotechnology, Other Health, Health, General Health, Public Relations, Investor Relations, Pharmaceutical, Oncology, Communications, Other Science, Research, Science, PDT, Bank, Conference

Incyte (Nasdaq:INCY) announced today that it will present at the Bank of America Securities 2024 Health Care Conference on Wednesday, May 15, 2024 at 8:00 a.m. (PDT) in Las Vegas.

Key Points: 
  • Incyte (Nasdaq:INCY) announced today that it will present at the Bank of America Securities 2024 Health Care Conference on Wednesday, May 15, 2024 at 8:00 a.m. (PDT) in Las Vegas.
  • The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

C3 AI to Announce Financial Results for Fourth Quarter and Fiscal Year 2024 on May 29, 2024

Retrieved on: 
Monday, April 29, 2024
Software, Technology, Artificial Intelligence, PDT, Enterprise, EDT, Webcast, PIN

C3 AI (NYSE: AI), the Enterprise AI application software company, today announced it will issue its financial results for the fiscal fourth quarter and full fiscal year 2024, which ends April 30, 2024, following the close of the U.S. markets on Wednesday, May 29, 2024.

Key Points: 
  • C3 AI (NYSE: AI), the Enterprise AI application software company, today announced it will issue its financial results for the fiscal fourth quarter and full fiscal year 2024, which ends April 30, 2024, following the close of the U.S. markets on Wednesday, May 29, 2024.
  • C3 AI will host a conference call and webcast to discuss the financial results.
  • The conference call will begin at 2:00 p.m. PDT / 5:00 p.m. EDT on May 29, 2024.
  • Access to the conference call is also available on the C3 AI Investor Relations website events page.